Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100786482 | 10078648 | 2 | F | 20150623 | 20150623 | 20140415 | 20150630 | EXP | US-SA-2014SA046307 | AVENTIS | 43.00 | YR | A | F | Y | 0.00000 | 20150630 | N | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100786482 | 10078648 | 1 | PS | FABRAZYME | AGALSIDASE BETA | 1 | Intravenous (not otherwise specified) | D | UNKNOWN | 103979 | 70 | MG | POWDER FOR SOLUTION FOR INFUSION | QOW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100786482 | 10078648 | 1 | Fabry's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100786482 | 10078648 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100786482 | 10078648 | Breast cancer | |
| 100786482 | 10078648 | Hypersensitivity | |
| 100786482 | 10078648 | Pain | |
| 100786482 | 10078648 | Pharyngitis streptococcal | |
| 100786482 | 10078648 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100786482 | 10078648 | 1 | 20090910 | 201403 | 0 |